|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 13/10 | (2006.01) |
| C12Q 1/6886 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C12Q2600/106 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| C12Q 1/6886 | (2018.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 16/2818 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| G16H 20/10 | (2018.01) | ||
| Y02A 90/10 | (2018.01) |
| (11) | Number of the document | 3423596 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17709892.8 |
| Date of filing the European patent application | 2017-02-27 | |
| (97) | Date of publication of the European application | 2019-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/019682 |
| Date | 2017-02-27 |
| (87) | Number | WO 2017/151502 |
| Date | 2017-09-08 |
| (30) | Number | Date | Country code |
| 201662301595 P | 2016-02-29 | US | |
| 201662405190 P | 2016-10-06 | US |
| (72) |
BOURGON, Richard , US
FABRIZIO, David , US
FINE, Gregg , US
FRAMPTON, Garrett, M. , US
HEGDE, Priti , US
MARIATHASAN, Sanjeev , US
STEPHENS, Philip J. , US
SUN, James, Xin , US
YELENSKY, Roman , US
|
| (73) |
Genentech, Inc. ,
1 DNA Way, South San Francisco, CA 94080-4990,
US
Foundation Medicine, Inc. , 150 Second Street, Cambridge, MA 02141, US |
| (54) | THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER |
| THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER |